Table 1 Phenotype–genotype correlation in CHH probands with CHD7 RSVs

From: Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants

Pt

Initial Dx

CHD7 RSVs

Other pathogenic variants

CHARGE features

Other phenotypes

Final Dx

ACMG criteria

    

Major

Minor

   
    

C

A

SCC

 

RED

E

ID

MO

HPD

   

1

KS

p.R2428*

+

+

 

+

+

Nasal cartilage distortion

CHARGE

P

2

KS

p.Y1412D

+

+

 

+

+

+

Oval palate

CHARGE

LP

3

KS

p.C989Y

+

 

+

+

+

Atropy of optic chiasma

Atypical CHARGE

LP

4

KS

p.A1107V

+

 

+

+

See Table 2

KS

LP

5

KS

p.F1019C

SEMA3E p.R619C

U

 

+

Dental defects

KS

LP

6

KS

p.A2730T

FGFR1 p.R365Kfs*5

 

+

+

+

Optic nerve atrophy, CLP, CC agenesis

KS

US

7

KS

p.Y1616C

SEMA3A p.R66W

 

+

+

KS

US

8

nCHH

p.Y1325H

 

+

+

nCHH

US

9M

KS

p.D1638E

 

M

+

Synkinesia, dental defect

KS

US

10

nCHH

c.2613+5G>A

FGFR1 p.S436Ffs*3

 

+

Skeletal defect

nCHH

US

11

nCHH

p.Q2833E

U

 

+

nCHH

US

12

nCHH

p.M340V

 

+

+

nCHH

B

13

nCHH

p.M340V

GNRHR p.[L89*];[L117R]

 

+

Dental defect, astigmatism

nCHH

B

14

KS

p.S466L

U

 

+

KS

B

15

nCHH

p.R2400Q

 

+

nCHH

LB

16

nCHH

p.M2527L

 

+

Dental defect, astigmatism

nCHH

LB

17

KS

p.L2806V

FGFR1 p.Tyr654*

 

+

KS

B

  1. A, choanal atresia; ACMG, American College of Medical Genetics and Genomics; B, benign; C, coloboma; CC, corpus callosum; CHH, congenital hypogonadotropic hypogonadism; CLP, cleft lip and palate; Dx, diagnosis; E, ear anomalies; HPD, hypothalamic–pituitary dysfunction; ID, intellectual disability; KS, Kallmann syndrome; LB, likely benign; LP, likely pathogenic; M, Marfan syndrome (confirmed by the identification of FBN1 p.R1692del and aorta root dilation in this proband); MO, mediastinal organ malformation (heart and esophagus); nCHH, normosmic CHH; P, pathogenic; Pt, patient; RED, rhemboencephalic dysfunction; RSV, rare sequencing variant; SCC, semicircular canals dysplasia; U, unknown; US, uncertain significance.
  2. CHARGE features and CHARGE diagnosis are according to the 2005 Verloes criteria.7